European heart journal · 2024
Tricuspid valve disease and cardiac implantable electronic devices.
ОбзорСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Andreas Martin, Burri Haran, Praz Fabien, Soliman Osama, Badano Luigi, Barreiro Manuel, Cavalcante João L, de Potter Tom, Doenst Torsten, Friedrichs Kai, Hausleiter Jörg, Karam Nicole, Kodali Susheel, Latib Azeem, Marijon Eloi, Mittal Suneet, Nickenig Georg, Rinaldi Aldo, Rudzinski Piotr Nikodem, Russo Marco, Starck Christoph, von Bardeleben Ralph Stephan, Wunderlich Nina, Zamorano José Luis, Hahn Rebecca T, Maisano Francesco, Leclercq Christophe
Аннотация
The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.